A Study on Immunogenicity of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® Using Accelerated Vaccination Schedule in Adults (Aged Over 18 Years)
Latest Information Update: 25 Feb 2019
At a glance
- Drugs Recombinant hepatitis E vaccine (Hecolin) (Primary)
- Indications Hepatitis E
- Focus Pharmacodynamics
- Sponsors Xiamen Innovax Biotech
- 19 Feb 2019 Status changed from not yet recruiting to completed.
- 02 Jun 2017 New trial record